These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29981458)

  • 1. Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD.
    Hassall D; Brealey N; Wright W; Hughes S; West A; Ravindranath R; Warren F; Daley-Yates P
    Pulm Pharmacol Ther; 2018 Aug; 51():59-64. PubMed ID: 29981458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
    Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DuoResp
    van der Palen J; Cerveri I; Roche N; Singh D; Plaza V; Gonzalez C; Patino O; Scheepstra I; Safioti G; Backer V
    J Asthma; 2020 Oct; 57(10):1110-1118. PubMed ID: 31293211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease].
    Sicras A; Ferrer V; Collar JM; Navarro R; Sáez M
    Semergen; 2017; 43(5):375-386. PubMed ID: 27425817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD.
    Weinstein C; Staudinger H; Scott I; Amar NJ; LaForce C
    Respir Med; 2011 Jul; 105(7):979-88. PubMed ID: 21398104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy.
    Bender BG; Hernandez Vecino RA; McGrath K; Jones S
    J Allergy Clin Immunol Pract; 2016; 4(5):884-9. PubMed ID: 27587319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.
    Toyama T; Kawayama T; Kinoshita T; Imamura Y; Yoshida M; Takahashi K; Fujii K; Higashimoto I; Hoshino T
    Intern Med; 2019 Jan; 58(2):175-185. PubMed ID: 30210101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients.
    Plaza V; López-Viña A; Entrenas LM; Fernández-Rodríguez C; Melero C; Pérez-Llano L; Gutiérrez-Pereyra F; Tarragona E; Palomino R; Cosio BG
    COPD; 2016 Oct; 13(5):547-54. PubMed ID: 26788620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease.
    Mudaliar S; Henry RR
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S83-92. PubMed ID: 17563308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?
    De Keyser H; Vuong V; Kaye L; Anderson WC; Szefler S; Stempel DA
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2087-2093.e3. PubMed ID: 37088377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of inhaled therapies for COPD and asthma].
    Gregoriano C; Tschacher A; Grendelmeier P; Cadus C
    Ther Umsch; 2019 Nov; 76(6):301-310. PubMed ID: 31762413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study.
    Price D; Lee AJ; Sims EJ; Kemp L; Hillyer EV; Chisholm A; von Ziegenweidt J; Williams A
    Prim Care Respir J; 2013 Jun; 22(2):161-8. PubMed ID: 23460035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.
    Sriram KB; Percival M
    Chron Respir Dis; 2016 Feb; 13(1):13-22. PubMed ID: 26396159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.